Telomere length is inherited with resetting of the telomere set-point.
We have studied models of telomerase haploinsufficiency in humans and mice to analyze regulation of telomere length and the significance of "set points" in inheritance of telomere length. In three families with clinical syndromes associated with short telomeres resulting from haploinsufficient mutations in TERT, the gene encoding telomerase reverse transcriptase, we asked whether restoration of normal genotypes in offspring of affected individuals would elongate inherited short telomeres. Telomeres were shorter than normal in some but not all genotypically normal offspring of telomerase-mutant parents or grandparents. Analysis of these findings was complicated by heterogeneity of telomere length among individuals, as well as by the admixing of telomeres inherited from affected parents with those inherited from unaffected ("wild-type" TERT) parents. To understand further the inheritance of telomere length, we established a shortened-telomere mouse model. When Tert(+/-) heterozygous mice were successively cross-bred through 17 generations, telomere length shortened progressively. The late-generation Tert(+/-) mice were intercrossed to produce genotypically wild-type Tert(+/+) mice, for which telomere length was characterized. Strikingly, telomere length in these Tert(+/+) mice was not longer than that of their Tert(+/-) parents. Moreover, when successive crosses were carried out among these short-telomere Tert(+/+) offspring mice, telomere length was stable, with no elongation up to six generations. This breeding strategy therefore has established a mouse strain, B6.ST (short telomeres), with C57BL/6 genotype and stable short telomeres. These findings suggest that the set point of telomere lengths of offspring is determined by the telomere lengths of their parents in the presence of normal expression of telomerase.
Chiang
Y Jeffrey
YJ
Experimental Immunology Branch, National Cancer Institute, Hematology Branch, National Heart, Lung and Blood Institute, and National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA. chiangj@mail.nih.gov
Calado
Rodrigo T
RT
Hathcock
Karen S
KS
Lansdorp
Peter M
PM
Young
Neal S
NS
Hodes
Richard J
RJ
D000741:Anemia, Aplastic / Q000235:genetics; D000818:Animals; D003433:Crosses, Genetic; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D008957:Models, Genetic; D009154:Mutation; D010375:Pedigree; D010641:Phenotype; D019098:Telomerase / Q000235:genetics; D016615:Telomere / Q000235:genetics* / Q000648:ultrastructure*
C509186:TERT protein, human; D019098:Telomerase; C509187:Tert protein, mouse